Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of Combining Metacognitive Training (MCT) With Cognitive Remediation (CR) in the Recovery of Patients With Psychotic Spectrum Disorders (CR+MCTp)

NCT06423651 is registered in ClinicalTrials.gov with Universitat Autonoma de Barcelona as lead sponsor.

NCT NCT06423651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06423651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of Combining Metacognitive Training (MCT) With Cognitive Remediation (CR) in the Recovery of Patients With Psychotic Spectrum Disorders (CR+MCTp)
Lead sponsor
Universitat Autonoma de Barcelona
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 31, 2025
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brief psychotic disorder, delusional disorder, schizoaffective disorder, schizophrenia, schizophrenia spectrum and other psychotic disorders, schizophreniform disorders